In the upcoming human trial, UTRxM1-18 will be used to target c-MYC driven tumors including triple negative breast cancer, pancreatic cancer, colorectal cancer and ovarian cancer. In animal studies, ...

In the upcoming human trial, UTRxM1-18 will be used to target c-MYC driven tumors including triple negative breast cancer, pancreatic cancer, colorectal cancer and ovarian cancer.

In “Matriarch,” a memoir out Tuesday, Beyoncé and Solange Knowles’s mom reveals she was diagnosed with breast cancer last year.

TNBC Thrivers is a support organization that provides encouragement, community, education, and events for anyone diagnosed with triple-negative breast cancer. Spotlight On: TNBC Thrivers ...

Learn about triple-negative breast cancer (TNBC), an aggressive form of breast cancer. Explore its symptoms, diagnosis, treatment options, and prognosis for better understanding and management. News ...

Various biomarkers, including T-cell inflamed 18-gene expression profile, were positively prognostic for improved pathologic complete response (pCR) and event-free survival (EFS), with or without the ...

WASHINGTON, November 19, 2024--TOUCH, The Black Breast Cancer Alliance (TOUCHBBCA)—in collaboration with the Triple Negative Breast Cancer Foundation, the American Association for Cancer ...

Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients ...

Triple-negative breast cancer (TNBC) is one of the deadliest subtypes of breast cancer (BC) for its high aggressiveness ... Another study reported by Lee et al., showed that the production of reactive ...

The c-Myc oncogene is overexpressed in a significant proportion of human cancers, including difficult-to-treat triple-negative breast cancers (TNBC). In the pursuit of novel anti-TNBC agents, there is ...

Triple-negative breast cancer (TNBC) is highly aggressive with a poor clinical prognosis and no targeted therapy. The c-Myc protein is a master transcription factor and a potential therapeutic target ...